As of 2024-12-11, the Relative Valuation of Aptose Biosciences Inc (APS.TO) is (12.91) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.28 CAD, the upside of Aptose Biosciences Inc based on Relative Valuation is -4709.6%.
The range of the Relative Valuation is (17.56) - (4.63) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.3x - 10.9x | 9.1x |
| Forward P/E multiples | 1.3x - 1.9x | 1.6x |
| Fair Price | (17.56) - (4.63) | (12.91) |
| Upside | -6372.6% - -1754.3% | -4709.6% |
| Date | P/E |
| 2024-12-02 | -0.15 |
| 2024-11-29 | -0.15 |
| 2024-11-27 | -0.15 |
| 2024-11-26 | -0.14 |
| 2024-11-25 | -0.15 |
| 2024-11-22 | -0.16 |
| 2024-11-21 | -0.20 |
| 2024-11-20 | -0.22 |
| 2024-11-19 | -0.29 |
| 2024-11-18 | -0.29 |
| 2024-11-15 | -0.30 |
| 2024-11-14 | -0.33 |
| 2024-11-13 | -0.31 |
| 2024-11-12 | -0.31 |
| 2024-11-11 | -0.32 |
| 2024-11-08 | -0.31 |
| 2024-11-07 | -0.31 |
| 2024-11-05 | -0.31 |
| 2024-11-04 | -0.32 |
| 2024-11-01 | -0.31 |
| 2024-10-31 | -0.30 |
| 2024-10-30 | -0.32 |
| 2024-10-29 | -0.31 |
| 2024-10-28 | -0.29 |
| 2024-10-25 | -0.30 |
| 2024-10-23 | -0.32 |
| 2024-10-22 | -0.31 |
| 2024-10-21 | -0.32 |
| 2024-10-18 | -0.32 |
| 2024-10-17 | -0.29 |
| 2024-10-16 | -0.28 |
| 2024-10-15 | -0.29 |
| 2024-10-11 | -0.28 |
| 2024-10-10 | -0.28 |
| 2024-10-09 | -0.28 |
| 2024-10-08 | -0.28 |
| 2024-10-07 | -0.28 |
| 2024-10-04 | -0.29 |
| 2024-10-03 | -0.30 |
| 2024-10-02 | -0.31 |
| 2024-10-01 | -0.31 |
| 2024-09-30 | -0.31 |
| 2024-09-27 | -0.33 |
| 2024-09-26 | -0.32 |
| 2024-09-25 | -0.32 |
| 2024-09-24 | -0.31 |
| 2024-09-23 | -0.31 |
| 2024-09-20 | -0.31 |
| 2024-09-19 | -0.31 |
| 2024-09-18 | -0.31 |